Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients

The preexistence of humoral immunity, which cross-reacts with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) protein due to prior endemic low-pathogenic human coronavirus infection, has been reported, but its role in coronavirus disease 2019 (COVID-19) outcomes remains elusive. We eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Taro, Shimakami, Tetsuro, Nio, Kouki, Terashima, Takeshi, Okajima, Masaki, Taniguchi, Takumi, Wada, Takashi, Honda, Masao, Gabata, Toshifumi, Ota, Kenji, Yanagihara, Katsunori, Kaneko, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267280/
https://www.ncbi.nlm.nih.gov/pubmed/35807155
http://dx.doi.org/10.3390/jcm11133870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267280/
https://www.ncbi.nlm.nih.gov/pubmed/35807155
http://dx.doi.org/10.3390/jcm11133870

Ejemplares similares